ProShare Advisors LLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 97 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$113,444
-24.9%
60,665
+0.7%
0.00%
Q2 2023$151,137
+78.5%
60,214
+24.5%
0.00%
Q1 2023$84,648
+19.6%
48,370
+190.5%
0.00%
Q4 2022$70,767
+253.8%
16,651
-1.6%
0.00%
Q3 2022$20,000
-45.9%
16,925
+12.4%
0.00%
Q1 2022$37,000
-28.8%
15,054
-22.9%
0.00%
Q4 2021$52,000
-57.0%
19,518
-19.3%
0.00%
Q3 2021$121,000
-30.5%
24,181
+3.8%
0.00%
-100.0%
Q2 2021$174,000
+159.7%
23,304
+104.0%
0.00%
Q1 2021$67,000
+11.7%
11,425
-10.0%
0.00%
Q4 2020$60,00012,6960.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 6,961,913$51,936,0000.23%
LEVIN CAPITAL STRATEGIES, L.P. 38,762$289,0000.03%
Riverview Trust Co 1,000$7,0000.01%
HoyleCohen, LLC 10,432$78,0000.01%
Baillie Gifford 436,512$3,256,0000.00%
Tower Research Capital LLC (TRC) 3,436$26,0000.00%
Renaissance Technologies 125,452$936,0000.00%
ProShare Advisors LLC 23,304$174,0000.00%
Bradley & Co. Private Wealth Management, LLC 200$1,0000.00%
FIL Ltd 104,100$777,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders